![Michael Silvon](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Michael Silvon currently works at Sannova Analytical, Inc., as Executive Chairman from 2022.
Cargos activos de Michael Silvon
Empresas | Cargo | Inicio |
---|---|---|
Sannova Analytical, Inc.
![]() Sannova Analytical, Inc. Miscellaneous Commercial ServicesCommercial Services Sannova Analytical, Inc. is a contract research organization that provides bioanalytical and chemistry manufacturing and controls testing services to biopharmaceutical and biotech companies for both small and large molecules. The company is based in Somerset, NJ and was founded in 2006 by Venkat Reddy, Geeta Vidiyala, and Malleswar Kollu. Sannova is known for its consistently low variability data, quick turnaround times, and over 300 validated methods. The company has completed over 1,200 clinical trials and has maintained an impeccable inspection record with the FDA and its sponsors. Sannova is considered a trusted and quality-focused partner in drug development by customers with a strong track record of regulatory compliance. Jason Apter has been the CEO of the company since 2022. | Presidente | 01/07/2022 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Sannova Analytical, Inc.
![]() Sannova Analytical, Inc. Miscellaneous Commercial ServicesCommercial Services Sannova Analytical, Inc. is a contract research organization that provides bioanalytical and chemistry manufacturing and controls testing services to biopharmaceutical and biotech companies for both small and large molecules. The company is based in Somerset, NJ and was founded in 2006 by Venkat Reddy, Geeta Vidiyala, and Malleswar Kollu. Sannova is known for its consistently low variability data, quick turnaround times, and over 300 validated methods. The company has completed over 1,200 clinical trials and has maintained an impeccable inspection record with the FDA and its sponsors. Sannova is considered a trusted and quality-focused partner in drug development by customers with a strong track record of regulatory compliance. Jason Apter has been the CEO of the company since 2022. | Commercial Services |
- Bolsa de valores
- Insiders
- Michael Silvon